Summary: Bone Health Technologies (BHT) has launched pre-orders for Osteoboost, the first FDA-cleared, non-drug wearable treatment designed to improve bone health in postmenopausal women with osteopenia using targeted vibration therapy. Key Takeaways: Innovative...
Bone Health Technologies (BHT), a medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health and reduce fractures, has acquired Wellen, a Brooklyn-based health technology company providing exercise-based osteoporosis care...
Bone Health Technologies (BHT), a medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia,...
Bone Health Technologies (BHT), an innovator of technologies for improving bone health and preventing bone health diseases, has received a $2.7 million grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH). The Commercialization...
Bone Health Technologies announces that the United States Patent and Trademark Office (USPTO) has awarded its second patent for the OsteoBoost Vibration Belt, which is specifically designed to treat osteopenia and prevent osteoporosis. This patent covers the...
